GARO H. ARMEN - 30 May 2025 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Officer, Director
Signature
/s/Christine M. Klaskin, as Attorney-in-Fact for Garo H. Armen
Issuer symbol
AGEN
Transactions as of
30 May 2025
Net transactions value
+$16,358
Form type
4
Filing time
03 Jun 2025, 16:05:27 UTC
Previous filing
20 May 2025
Next filing
17 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ARMEN GARO H Officer, Director C/O AGENUS INC., 3 FORBES ROAD, LEXINGTON /s/Christine M. Klaskin, as Attorney-in-Fact for Garo H. Armen 02 Jun 2025 0000935679

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGEN Common Stock Award $16,358 +4,769 +2.6% $3.43 190,529 30 May 2025 Direct F1, F2
holding AGEN Common Stock 31,298 30 May 2025 See Footnote F3
holding AGEN Common Stock 28,950 30 May 2025 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending May 30, 2025. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
F2 $3.43 is the closing price of our Common Stock on May 30, 2025, the last trading day for the payroll date for the pay period ending May 30, 2025.
F3 Shares are held in Dr. Armen's IRA accounts.
F4 Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.